Combining Ashland's strength in nutrition and food science with Pharmachem's ingredient processing expertise in renamed Health and Wellness unit
WILMINGTON, DE, November 28, 2017 - Ashland (NYSE: ASH) is taking aim at the fast-growing global nutraceuticals market by combining its nutrition business with the ingredients processing expertise of recently acquired Pharmachem. The combined unit, which will be called Health and Wellness, will continue to report up through Ashland's Specialty Ingredients segment.
"Our plan is to fulfill the growing needs of a thriving and ever-changing global marketplace for nutraceutical products, including dietary supplements, food and beverages," said David Neuberger, group vice president, pharmaceutical, nutrition and agriculture. "We intend to harness the synergy created between Ashland and Pharmachem to help us fully capitalize on emerging trends in the nutraceutical marketplace and food-based supplements."
He added: "We are combining the expertise and knowledge of two great companies and expanding our functional food platform on a global basis. It will
enable us to utilize Ashland's comprehensive food science capabilities, along with Pharmachem's advanced ingredient process services expertise, to develop innovative new products for the nutra-food and beverage industry."
Colin MacIntyre, Pharmachem executive vice president and general manager, said: "Ashland's technical knowledge of food science will add a valuable new dimension to our ingredient processing capabilities, and enable the new division to respond quickly and seamlessly to the needs of brand marketers."
Ashland has helped customers address global trends in food and beverage development - from stabilizing sugar reduced beverages to adapting foods for gluten-free diets.
About Ashland
Ashland Global Holdings Inc. (NYSE: ASH) is a premier global specialty chemicals company serving customers in a wide range of consumer and industrial markets, including adhesives, architectural coatings, automotive, construction, energy, food and beverage, personal care and pharmaceutical. At Ashland, we are approximately 6,500 passionate, tenacious solvers - from renowned scientists and research chemists to talented engineers and plant operators - who thrive on developing
practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit ashland.com to learn more.
C-ASH
(TM) Trademark, Ashland or its subsidiaries, registered in various countries.
FOR FURTHER INFORMATION:
Investor Relations:
Seth A. Mrozek
+1 (859) 815-3527
samrozek@ashland.com
Media Relations:
Gary Rhodes
+1 (859) 815-3047
glrhodes@ashland.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ashland Inc. via Globenewswire
News Provided by Acquire Media
